Antibiotik Profilaksis Pada Penyakit Jantung

Musa Ghufron(1*), Muhammad Perdana Airlangga(2)


(1) FK UMSurabaya, Surabaya, East Java, Indonesia
(2) FK UMSurabaya, Surabaya, East Java, Indonesia
(*) Corresponding Author

Abstract


Prophylactic Antibiotics in Heart Disease

Infective endocarditis (IE) is an uncommon but lifethreatening infection. Despite advances in diagnosis, antimicrobial therapy, surgical techniques, and management of complications, patients with IE still have high morbidity and mortality rates related to this condition. Since the last American Heart Association (AHA) publication on prevention of IE in 1997, many authorities and societies, as well as the conclusions of published studies, have questioned the efficacy of antimicrobial prophylaxis to prevent IE in patients who undergo a dental, gastrointestinal (GI), or genitourinary (GU) tract procedure and have suggested that guidelines should be revised


Keywords


infective; endocarditis; prophylaxis; antibiotic

Full Text:

PDF

References


Habib G, Hoen B, Tornos P, et al. Guidelines on prevention, diagnosis and treatment of infective endocarditis executive summary; the task force on infective endocarditis of the European society of cardiology. Eur Heart J2009;30:2369-2413.

Prendergast BD. The changing face of infective endocarditis. Heart2006;92(7):879–85.

Hill EE, Herijgers P, Claus P, Vanderschueren S, Herregods MC, Peetermans WE.Infective endocarditis: changing epidemiology and predictors of 6-month mortality:a prospective cohort study. Eur Heart J2007;28:196–203

Cabell CH Jr., Jollis JG, Peterson GE, Corey GR, Anderson DJ, Sexton DJ,Woods CW, Reller LB, Ryan T, Fowler VG Jr. Changing patient characteristicsand the effect on mortality in endocarditis. Arch Intern Med2002;162:90–94.

Hunter D, Pepper J. Infective Endocarditis. In: Griffiths M, Cordingley JJ, Price S ed. Cardiovascular Critical Care. Wiley-Blackwell;2010:347-346

Wang A, Cabell CA. Infective Endocarditis. In: Wang A, Bashore TM. Valvular Heart Disease. Humana Press;2009:475-498

Starkebaum M, Durack D, Beeson P. The “incubation period” ofsubacute bacterial endocarditis. Yale J Biol Med 1977;50(1):49-58.

Hutto C, Pallasch TJ, Gage TW, Levison ME, Peter G,Zuccaro G, Jr. Prevention of bacterial endocarditis: recommendationsby AHA. Circulation 1997; 96:358–366.

Wilson W, Taubert KA, Gewitz M, et al. Prevention of infective endocarditis. Guidelines from the American Heart Association. A guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation 2007;115

Gould FK, Elliott TS, Foweraker J, et al. Guidelines for the prevention ofendocarditis: report of the Working Party of the British Society forAntimicrobial Chemotherapy. J Antimicrob Chemother 2006;57(6):1035–42.

NICE. Prophylaxis Against Infective Endocarditis. 2008.

Prevention of infective endocarditis: Guidelines from the American Heart Association.JADA 2008;139(1):3S-24S.

Roberts GJ. Dentists are innocent! “Everyday” bacteremia is thereal culprit: a review and assessment of the evidence that dental surgicalprocedures are a principal cause of bacterial endocarditis in children.Pediatr Cardiol 1999;20(5):317-25.

DeSimone DC, Tleyjeh, IM, Correa de Sa DD, et al. Incidence of infective endocarditis caused by viridans group streptococci before and after publication of the 2007 American Heart Antibiotik Profilaksis Pada Penyakit Jantung50Vol.6No.1Februari2019Association's Endocarditis Prevention Guidelines. Circulation2012;126:60-64.

Duval X et al. Temporal trends in infective endocarditis in the context of prophylaxis guideline modifications: Three successive population-based surveys. J Am Coll Cardiol2012 May 29; 59:1968.

Thornhill MH, Dayer MJ, Forde JM, et al. Impact of the NICE guideline recommending cessation of antibiotic prophylaxis for prevention of infective endocarditis: before and after study. BMJ2011; 342:d2392


Article Metrics

Abstract view : 1175 times
PDF - 536 times

DOI: https://doi.org/10.26714/magnamed.6.1.2019.38-50

Refbacks

  • There are currently no refbacks.




Indexed by

 

      

 

Creative Commons License

MAGNA MEDIKA by APKKM is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.